Therapeutically, many advanced colon cancers and their metastases are predicted to be refractory to WNT-TCF signaling inhibition (Varnat et al, 2010), and this treatment could be counterproductive (this work). This evidence concerns the gene HNF4A and malignant colon neoplasm.